BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 18167116)

  • 1. Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis.
    Doucet MY; Bertone AL; Hendrickson D; Hughes F; Macallister C; McClure S; Reinemeyer C; Rossier Y; Sifferman R; Vrins AA; White G; Kunkle B; Alva R; Romano D; Hanson PD
    J Am Vet Med Assoc; 2008 Jan; 232(1):91-7. PubMed ID: 18167116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of oral administration of firocoxib for the management of musculoskeletal pain and lameness associated with osteoarthritis in horses.
    Orsini JA; Ryan WG; Carithers DS; Boston RC
    Am J Vet Res; 2012 May; 73(5):664-71. PubMed ID: 22533398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of firocoxib in the management of canine osteoarthritis under field conditions.
    Hanson PD; Brooks KC; Case J; Conzemius M; Gordon W; Schuessler J; Shelley B; Sifferman R; Drag M; Alva R; Bell L; Romano D; Fleishman C
    Vet Ther; 2006; 7(2):127-40. PubMed ID: 16871495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and safety of firocoxib in the treatment of dogs with osteoarthritis.
    Autefage A; Palissier FM; Asimus E; Pepin-Richard C
    Vet Rec; 2011 Jun; 168(23):617. PubMed ID: 21642297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses.
    Keegan KG; Messer NT; Reed SK; Wilson DA; Kramer J
    Am J Vet Res; 2008 Feb; 69(2):167-73. PubMed ID: 18241011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance of firocoxib in dogs with osteoarthritis during 90 days.
    Lecoindre O; Pepin-Richard C
    J Vet Pharmacol Ther; 2011 Apr; 34(2):190-2. PubMed ID: 21395612
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical effectiveness and safety of a new NSAID, firocoxib: a 1,000 dog study.
    Ryan WG; Moldave K; Carithers D
    Vet Ther; 2006; 7(2):119-26. PubMed ID: 16871494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the safety of a combination of oral administration of phenylbutazone and firocoxib in horses.
    Kivett L; Taintor J; Wright J
    J Vet Pharmacol Ther; 2014 Aug; 37(4):413-6. PubMed ID: 24354928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis.
    Pollmeier M; Toulemonde C; Fleishman C; Hanson PD
    Vet Rec; 2006 Oct; 159(17):547-51. PubMed ID: 17056650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of firocoxib or flunixin meglumine on recovery of ischemic-injured equine jejunum.
    Cook VL; Meyer CT; Campbell NB; Blikslager AT
    Am J Vet Res; 2009 Aug; 70(8):992-1000. PubMed ID: 19645580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of topically administered diclofenac liposomal cream for treatment of horses with experimentally induced osteoarthritis.
    Frisbie DD; McIlwraith CW; Kawcak CE; Werpy NM; Pearce GL
    Am J Vet Res; 2009 Feb; 70(2):210-5. PubMed ID: 19231953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised, double-blinded, placebo-controlled study on the efficacy of a unique extract of green-lipped mussel (Perna canaliculus) in horses with chronic fetlock lameness attributed to osteoarthritis.
    Cayzer J; Hedderley D; Gray S
    Equine Vet J; 2012 Jul; 44(4):393-8. PubMed ID: 21883418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of firocoxib (Previcox) in geriatric dogs over a period of 90 days.
    Joubert KE
    J S Afr Vet Assoc; 2009 Sep; 80(3):179-84. PubMed ID: 20169752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of force plate measurements to titrate the dosage of a new COX-2 inhibitor in lame horses.
    Back W; MacAllister CG; van Heel MC; Pollmeier M; Hanson PD
    Equine Vet J; 2009 Mar; 41(3):309-12. PubMed ID: 19469242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pretreatment with ketoprofen and phenylbutazone on experimentally induced synovitis in horses.
    Owens JG; Kamerling SG; Stanton SR; Keowen ML; Prescott-Mathews JS
    Am J Vet Res; 1996 Jun; 57(6):866-74. PubMed ID: 8725815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching NSAIDs in practice: insights from the Previcox (firocoxib) Experience Trial.
    Ryan WG; Moldave K; Carithers D
    Vet Ther; 2007; 8(4):263-71. PubMed ID: 18183545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effect of extracorporeal shock wave treatment on experimentally induced osteoarthritis in middle carpal joints of horses.
    Frisbie DD; Kawcak CE; McIlwraith CW
    Am J Vet Res; 2009 Apr; 70(4):449-54. PubMed ID: 19335099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of single-dose intravenous phenylbutazone and flunixin meglumine before, during and after exercise in an experimental reversible model of foot lameness in horses.
    Foreman JH; Grubb TL; Inoue OJ; Banner SE; Ball KT
    Equine Vet J Suppl; 2010 Nov; (38):601-5. PubMed ID: 21059067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of selective versus nonselective cyclooxygenase inhibitors on gastric ulceration scores and intestinal inflammation in horses.
    Richardson LM; Whitfield-Cargile CM; Cohen ND; Chamoun-Emanuelli AM; Dockery HJ
    Vet Surg; 2018 Aug; 47(6):784-791. PubMed ID: 30094858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis.
    Frisbie DD; Kawcak CE; Werpy NM; Park RD; McIlwraith CW
    Am J Vet Res; 2007 Mar; 68(3):290-6. PubMed ID: 17331019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.